INEOS Nitriles has confirmed the world first sales of InvireoTM a new bio-based acrylonitrile, a raw material necessary in the production of carbon fibre.
![shutterstock_1391245112.jpg shutterstock_1391245112.jpg](https://www.medicalplasticsnews.com/downloads/10408/download/shutterstock_1391245112.jpg?cb=17a48ac2fe07bb8e32c7033d2047bf22&w={width}&h={height})
shltz Shutterstock
INVIREOTM acrylonitrile is produced via a controlled and certified (ISCC+) mass balance route which allows INEOS Nitriles to offer customers products with a 90% reduction in their carbon footprint vs. conventional acrylonitrile-based products.
Carbon fibre is increasingly used across a variety of applications as a lightweight yet durable alternative to aluminium, titanium and steel.
Gordon Adams, business director for INEOS Nitriles and INEOS Phenol businesses said: “This is a significant milestone in the delivery of INEOS Nitriles sustainability strategy. Our new bio-based acrylonitrile has the potential to significantly cut the carbon footprint of a variety of everyday industries. Consumers and businesses alike are looking for improved sustainability for their products, and this new acrylonitrile delivers that.”